首页|含咪唑并[1,2-a]吡啶苯基甲酮类衍生物的合成及抗肿瘤活性评价

含咪唑并[1,2-a]吡啶苯基甲酮类衍生物的合成及抗肿瘤活性评价

扫码查看
目的 合成含咪唑并[1,2-a]吡啶苯基甲酮类衍生物,进一步探讨其抗肿瘤活性。方法 以色酮和炔醇作为起始原料,利用[3+2]环加成策略直接合成了一系列咪唑并[1,2-a]吡啶C3酮衍生物,并通过质谱和核磁确定了其结构。通过CCK8的方法,测试目标化合物对MV4-11,A549和HepG2 3种细胞系的抗增殖作用。通过Docking方法,探讨这些化合物与Fms样酪氨酸激酶3(FLT3)蛋白结合口袋的相互作用。结果 成功合成了咪唑并[1,2-a]吡啶C3酮衍生物,大部分化合物对MV4-11细胞具有好的抑制作用,其中化合物4j和4l的半数抑制浓度IC50值分别为22。3、24。1 μmol/L,化合物5b的抑制率超过70%。Docking分析表明,这类结构能够靶向FLT3蛋白的结合口袋,与Quizartinib的核心骨架能较好叠合并与周围氨基酸残基形成π-H相互作用。结论 这类化合物有望作为关键片段替换Quizartinib骨架结构来设计开发新的FLT3抑制剂用于急性髓系白血病的治疗。
The synthesis and evaluation of phenyl methanone bearing imidazo[1,2-a]pyr-idine derivatives for antitumor activity
Objective To synthesize imidazo[1,2-a]pyridine derivatives,and further explore the anti-tumor ac-tivity of imidazo[1,2-a]pyridine phenyl ketone derivatives.Methods A series of imidazo[1,2-a]pyridine C3-ketone derivatives were synthesized directly using a[3+2]cycloaddition strategy from chromone and alkynol,and their structures were confirmed by mass spectrometry and NMR.The anti-proliferative effects of the target compounds on MV4-11,A549,and HepG2 cell lines were tested using the CCK8 method.The interaction be-tween these compounds and the binding pocket of the Fms Like Tyrosine Kinase 3(FLT3)protein was explored using Docking analysis.Results The imidazo[1,2-a]pyridine C3-ketone derivatives were successfully synthe-sized.Most compounds showed good inhibitory activity against MV4-11 cells.Among them,compounds 4j and 4l showed IC50 values of 22.3 μmol/L and 24.1 μmol/L,respectively,while compound 5b had an inhibition rate more than 70%.Docking analysis revealed that this skeleton can target the binding pocket of the FLT3 protein,and can effectively overlap with the core framework of quizartinib and form π-H interactions with surrounding a-mino acid residues.Conclusion These compounds are expected to serve as key fragments to replace the core pharmacophore of quizartinib in the design and development of new FLT3 inhibitors for the treatment of acute my-eloid leukemia.

imidazo[1,2-a]pyridineantitumorantiproliferationactivities of cellssynthesis

黎江东、吴律嘉、幸黔鲁、施吉海、赵长阔、朱蕾、黄强、麻小娟

展开 >

遵义医科大学公共卫生学院,贵州遵义 563006

遵义医科大学药学院,贵州遵义 563006

遵义医科大学第二附属医院儿科,贵州遵义 563006

咪唑并[1,2-a]吡啶 抗肿瘤 抗增殖 细胞活性 合成

国家自然科学基金地区科学基金贵州省科技厅基础研究计划贵州省科技厅基础研究计划

82360679黔科合基础-ZK2022一般592黔科合基础20201Y351

2024

遵义医科大学学报
遵义医科大学

遵义医科大学学报

CSTPCD
ISSN:2096-8159
年,卷(期):2024.47(6)
  • 24